Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tineke van den Hoorn

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Immunology|October 22, 2008
Activated pDCs: open to new antigen-presentation possibilitiesTineke van den Hoorn, Jacques Neefjes
Current Opinion in Immunology|November 30, 2010
Routes to manipulate MHC class II antigen presentationTineke van den Hoorn, Petra Paul, Marlieke L M Jongsma, et al.
Journal of Cell Science|February 4, 2012
Dynamics within tetraspanin pairs affect MHC class II expressionTineke van den Hoorn, Petra Paul, Lennert Janssen, et al.
Molecular Biology of the Cell|November 14, 2009
Mobility, microtubule nucleation and structure of microtubule-organizing centers in multinucleated hyphae of Ashbya gossypiiClaudia Lang, Sandrine Grava, Tineke van den Hoorn, et al.
British Journal of Clinical Pharmacology|September 16, 2020
Animal-free applications in the development of cell-based therapiesPeter van Meer, Peter Theunissen, Tineke van den Hoorn, et al.
British Journal of Clinical Pharmacology|August 14, 2020
Mining scientific advice reports on cell-based products: Insight into the nonclinical development programTineke van den Hoorn, Tahira Nakchedi, A Charlotte M T de Wolf, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 26, 2021
Physiologically Relevant Estrogen Receptor Alpha Pathway Reporters for Single-Cell Imaging-Based Carcinogenic Hazard Assessment of Estrogenic CompoundsBritt Duijndam, Annabel Goudriaan, Tineke van den Hoorn, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 21, 2022
Evaluation of an imaging-based in vitro screening platform for estrogenic activity with OECD reference chemicalsBritt Duijndam, Massimo Tedeschi, Wanda van der Stel, et al.
The European Respiratory Journal|October 9, 2025
The European Medicines Agency's review of elexacaftor/tezacaftor/ivacaftor: extending its use to all people with cystic fibrosis aged 2 years and older who do not have two class I <i>CFTR</i> variantsCatherine Drai, Hanneke J van der Woude, Anne J Lexmond, et al.
Cell|April 5, 2011
A Genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentationPetra Paul, Tineke van den Hoorn, Marlieke L M Jongsma, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Immunology|October 22, 2008
Activated pDCs: open to new antigen-presentation possibilitiesTineke van den Hoorn, Jacques Neefjes
Current Opinion in Immunology|November 30, 2010
Routes to manipulate MHC class II antigen presentationTineke van den Hoorn, Petra Paul, Marlieke L M Jongsma, et al.
Journal of Cell Science|February 4, 2012
Dynamics within tetraspanin pairs affect MHC class II expressionTineke van den Hoorn, Petra Paul, Lennert Janssen, et al.
Molecular Biology of the Cell|November 14, 2009
Mobility, microtubule nucleation and structure of microtubule-organizing centers in multinucleated hyphae of Ashbya gossypiiClaudia Lang, Sandrine Grava, Tineke van den Hoorn, et al.
British Journal of Clinical Pharmacology|September 16, 2020
Animal-free applications in the development of cell-based therapiesPeter van Meer, Peter Theunissen, Tineke van den Hoorn, et al.
British Journal of Clinical Pharmacology|August 14, 2020
Mining scientific advice reports on cell-based products: Insight into the nonclinical development programTineke van den Hoorn, Tahira Nakchedi, A Charlotte M T de Wolf, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 26, 2021
Physiologically Relevant Estrogen Receptor Alpha Pathway Reporters for Single-Cell Imaging-Based Carcinogenic Hazard Assessment of Estrogenic CompoundsBritt Duijndam, Annabel Goudriaan, Tineke van den Hoorn, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 21, 2022
Evaluation of an imaging-based in vitro screening platform for estrogenic activity with OECD reference chemicalsBritt Duijndam, Massimo Tedeschi, Wanda van der Stel, et al.
The European Respiratory Journal|October 9, 2025
The European Medicines Agency's review of elexacaftor/tezacaftor/ivacaftor: extending its use to all people with cystic fibrosis aged 2 years and older who do not have two class I <i>CFTR</i> variantsCatherine Drai, Hanneke J van der Woude, Anne J Lexmond, et al.
Cell|April 5, 2011
A Genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentationPetra Paul, Tineke van den Hoorn, Marlieke L M Jongsma, et al.
Pageof 2